198 related articles for article (PubMed ID: 24503087)
1. Protection of non-human primates against rabies with an adenovirus recombinant vaccine.
Xiang ZQ; Greenberg L; Ertl HC; Rupprecht CE
Virology; 2014 Feb; 450-451():243-9. PubMed ID: 24503087
[TBL] [Abstract][Full Text] [Related]
2. Adult dogs receiving a rabies booster dose with a recombinant adenovirus expressing rabies virus glycoprotein develop high titers of neutralizing antibodies.
Tims T; Briggs DJ; Davis RD; Moore SM; Xiang Z; Ertl HC; Fu ZF
Vaccine; 2000 Jun; 18(25):2804-7. PubMed ID: 10812222
[TBL] [Abstract][Full Text] [Related]
3. A simian-adenovirus-vectored rabies vaccine suitable for thermostabilisation and clinical development for low-cost single-dose pre-exposure prophylaxis.
Wang C; Dulal P; Zhou X; Xiang Z; Goharriz H; Banyard A; Green N; Brunner L; Ventura R; Collin N; Draper SJ; Hill AVS; Ashfield R; Fooks AR; Ertl HC; Douglas AD
PLoS Negl Trop Dis; 2018 Oct; 12(10):e0006870. PubMed ID: 30372438
[TBL] [Abstract][Full Text] [Related]
4. [Immune efficacy of rabies virus glycoprotein expressed by baculovirus vector].
Chen Q; Zhang SF; Liu Y; Fu YH; Sun CL; Yang Y; Gong T; Song FF; Hu RL
Bing Du Xue Bao; 2012 Sep; 28(5):501-5. PubMed ID: 23233923
[TBL] [Abstract][Full Text] [Related]
5. A chimpanzee-origin adenovirus vector expressing the rabies virus glycoprotein as an oral vaccine against inhalation infection with rabies virus.
Zhou D; Cun A; Li Y; Xiang Z; Ertl HC
Mol Ther; 2006 Nov; 14(5):662-72. PubMed ID: 16797238
[TBL] [Abstract][Full Text] [Related]
6. A chimpanzee adenoviral vector-based rabies vaccine protects beagle dogs from lethal rabies virus challenge.
Wang X; Fang Z; Xiong J; Yang K; Chi Y; Tang X; Ma L; Zhang R; Deng F; Lan K; Zhou D
Virology; 2019 Oct; 536():32-38. PubMed ID: 31394410
[TBL] [Abstract][Full Text] [Related]
7. Feline herpesvirus vectored-rabies vaccine in cats: A dual protection.
Chen T; Zhou X; Qi Y; Mi L; Sun X; Zhang S; Liu Y; Olson V; Qiu W; Wu X; Hu R
Vaccine; 2019 Apr; 37(16):2224-2231. PubMed ID: 30878247
[TBL] [Abstract][Full Text] [Related]
8. A next generation vaccine against human rabies based on a single dose of a chimpanzee adenovirus vector serotype C.
Napolitano F; Merone R; Abbate A; Ammendola V; Horncastle E; Lanzaro F; Esposito M; Contino AM; Sbrocchi R; Sommella A; Duncan JD; Hinds J; Urbanowicz RA; Lahm A; Colloca S; Folgori A; Ball JK; Nicosia A; Wizel B; Capone S; Vitelli A
PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008459. PubMed ID: 32667913
[TBL] [Abstract][Full Text] [Related]
9. A replication-defective human adenovirus recombinant serves as a highly efficacious vaccine carrier.
Xiang ZQ; Yang Y; Wilson JM; Ertl HC
Virology; 1996 May; 219(1):220-7. PubMed ID: 8623532
[TBL] [Abstract][Full Text] [Related]
10. Codon optimization of G protein enhances rabies virus-induced humoral immunity.
Pei J; Huang F; Wu Q; Luo Z; Zhang Y; Ruan J; Li Y; Zhou M; Fu Z; Zhao L
J Gen Virol; 2019 Aug; 100(8):1222-1233. PubMed ID: 31259681
[TBL] [Abstract][Full Text] [Related]
11. Parainfluenza virus 5 expressing the G protein of rabies virus protects mice after rabies virus infection.
Huang Y; Chen Z; Huang J; Fu Z; He B
J Virol; 2015 Mar; 89(6):3427-9. PubMed ID: 25552723
[TBL] [Abstract][Full Text] [Related]
12. Immunogenicity of ORFV-based vectors expressing the rabies virus glycoprotein in livestock species.
Martins M; Joshi LR; Rodrigues FS; Anziliero D; Frandoloso R; Kutish GF; Rock DL; Weiblen R; Flores EF; Diel DG
Virology; 2017 Nov; 511():229-239. PubMed ID: 28898730
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the protective efficacy between single and combination of recombinant adenoviruses expressing complete and truncated glycoprotein, and nucleoprotein of the pathogenic street rabies virus in mice.
Kim HH; Yang DK; Nah JJ; Song JY; Cho IS
Virol J; 2017 Jun; 14(1):122. PubMed ID: 28646885
[TBL] [Abstract][Full Text] [Related]
14. [The induction of protective immune response in mice vaccinated by recombinant avian adenovirus CELO expressing glycoprotein G of the rabies virus].
Shmarov MM; Tutykhina IL; Logunov DIu; Verkhovskai LV; Nedosekov VV; Tsybanov SZh; Novikov BV; Narodnitskiĭ BS; Gintsburg AL
Zh Mikrobiol Epidemiol Immunobiol; 2006; (4):69-71. PubMed ID: 16941876
[TBL] [Abstract][Full Text] [Related]
15. Newcastle disease virus-vectored rabies vaccine is safe, highly immunogenic, and provides long-lasting protection in dogs and cats.
Ge J; Wang X; Tao L; Wen Z; Feng N; Yang S; Xia X; Yang C; Chen H; Bu Z
J Virol; 2011 Aug; 85(16):8241-52. PubMed ID: 21632762
[TBL] [Abstract][Full Text] [Related]
16. Genetically modified rabies virus ERA strain is safe and induces long-lasting protective immune response in dogs after oral vaccination.
Shuai L; Feng N; Wang X; Ge J; Wen Z; Chen W; Qin L; Xia X; Bu Z
Antiviral Res; 2015 Sep; 121():9-15. PubMed ID: 26093157
[TBL] [Abstract][Full Text] [Related]
17. Induction of protective immunity by topic application of a recombinant adenovirus expressing rabies virus glycoprotein.
Lees CY; Briggs DJ; Wu X; Davis RD; Moore SM; Gordon C; Xiang Z; Ertl HC; Tang DC; Fu ZF
Vet Microbiol; 2002 Apr; 85(4):295-303. PubMed ID: 11856579
[TBL] [Abstract][Full Text] [Related]
18. A novel approach to a rabies vaccine based on a recombinant single-cycle flavivirus vector.
Giel-Moloney M; Rumyantsev AA; David F; Figueiredo M; Feilmeier B; Mebatsion T; Parrington M; Kleanthous H; Pugachev KV
Vaccine; 2017 Dec; 35(49 Pt B):6898-6904. PubMed ID: 28899628
[TBL] [Abstract][Full Text] [Related]
19. A recombinant human adenovirus vaccine against rabies.
Prevec L; Campbell JB; Christie BS; Belbeck L; Graham FL
J Infect Dis; 1990 Jan; 161(1):27-30. PubMed ID: 2295855
[TBL] [Abstract][Full Text] [Related]
20. ICAM-1-based rabies virus vaccine shows increased infection and activation of primary murine B cells in vitro and enhanced antibody titers in-vivo.
Norton JE; Lytle AG; Shen S; Tzvetkov EP; Dorfmeier CL; McGettigan JP
PLoS One; 2014; 9(1):e87098. PubMed ID: 24489846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
